CuraSen Therapeutics Expands Management Team; Appoints Peter Butera as Senior Vice President, Operations by Seini Moimoi | Sep 10, 2019 | Portfolio News
Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation SYstem by Seini Moimoi | Sep 9, 2019 | Portfolio News
Nabriva’s XENLETA™ (lefamulin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP) Now Available in the U.S. by Seini Moimoi | Sep 9, 2019 | Portfolio News
Nabriva Therapeutics Earns $5 Million Milestone Payment under its License Agreement with Sinovant Sciences by Seini Moimoi | Sep 6, 2019 | Portfolio News
Former Principal Deputy Commissioner of FDA, Dr. Rachel Sherman, Joins Aptinyx Board of Directors by Seini Moimoi | Sep 4, 2019 | Portfolio News
